BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 36795484)

  • 21. Collagen Remodeling in the Hypoxic Tumor-Mesothelial Niche Promotes Ovarian Cancer Metastasis.
    Natarajan S; Foreman KM; Soriano MI; Rossen NS; Shehade H; Fregoso DR; Eggold JT; Krishnan V; Dorigo O; Krieg AJ; Heilshorn SC; Sinha S; Fuh KC; Rankin EB
    Cancer Res; 2019 May; 79(9):2271-2284. PubMed ID: 30862717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of fascin in cancer and stromal cells blocks ovarian cancer metastasis.
    McGuire S; Kara B; Hart PC; Montag A; Wroblewski K; Fazal S; Huang XY; Lengyel E; Kenny HA
    Gynecol Oncol; 2019 May; 153(2):405-415. PubMed ID: 30797592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic analyses reveal long non-coding RNA (PTAF)-mediated promotion of EMT and invasion-metastasis in serous ovarian cancer.
    Liang H; Zhao X; Wang C; Sun J; Chen Y; Wang G; Fang L; Yang R; Yu M; Gu Y; Shan H
    Mol Cancer; 2018 Jun; 17(1):96. PubMed ID: 29929545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PRSS21/testisin inhibits ovarian tumor metastasis and antagonizes proangiogenic angiopoietins ANG2 and ANGPTL4.
    Conway GD; Buzza MS; Martin EW; Duru N; Johnson TA; Peroutka RJ; Pawar NR; Antalis TM
    J Mol Med (Berl); 2019 May; 97(5):691-709. PubMed ID: 30911775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adipose-derived stem cells promote glycolysis and peritoneal metastasis via TGF-β1/SMAD3/ANGPTL4 axis in colorectal cancer.
    Zhu C; Teng L; Lai Y; Yao X; Fang Y; Wang Z; Lin S; Zhang H; Li Q; Li Y; Cai J; Zhang Y; Wu C; Huang B; Li A; Liu S; Lai Q
    Cell Mol Life Sci; 2024 Apr; 81(1):189. PubMed ID: 38643448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin.
    Kenny HA; Kaur S; Coussens LM; Lengyel E
    J Clin Invest; 2008 Apr; 118(4):1367-79. PubMed ID: 18340378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of the bi-directional cross-talk between ovarian cancer cells and adipocytes by SPARC.
    John B; Naczki C; Patel C; Ghoneum A; Qasem S; Salih Z; Said N
    Oncogene; 2019 May; 38(22):4366-4383. PubMed ID: 30765860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reciprocal crosstalk between Th17 and mesothelial cells promotes metastasis-associated adhesion of ovarian cancer cells.
    Neuhaus F; Lieber S; Shinkevich V; Steitz AM; Raifer H; Roth K; Finkernagel F; Worzfeld T; Burchert A; Keber C; Nist A; Stiewe T; Reinartz S; Beutgen VM; Graumann J; Pauck K; Garn H; Gaida M; Müller R; Huber M
    Clin Transl Med; 2024 Apr; 14(4):e1604. PubMed ID: 38566518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ANGPTL4 functions as an oncogene through regulation of the ETV5/CDH5/AKT/MMP9 axis to promote angiogenesis in ovarian cancer.
    Liu Y; Yang R; Zhang Y; Zhu Y; Bao W
    J Ovarian Res; 2022 Dec; 15(1):131. PubMed ID: 36517864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer.
    Li HZ; Wang Y; Gao Y; Shao J; Zhao XL; Deng WM; Liu YX; Yang J; Yao Z
    Mol Cancer Res; 2008 Jun; 6(6):917-28. PubMed ID: 18567796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2/STAT3 pathway and interacting with ESM1.
    Li YK; Gao AB; Zeng T; Liu D; Zhang QF; Ran XM; Tang ZZ; Li Y; Liu J; Zhang T; Shi GQ; Zhou WC; Zou WD; Peng J; Zhang J; Li H; Zou J
    J Transl Med; 2024 Jan; 22(1):46. PubMed ID: 38212795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis.
    Sandoval P; Jiménez-Heffernan JA; Rynne-Vidal Á; Pérez-Lozano ML; Gilsanz Á; Ruiz-Carpio V; Reyes R; García-Bordas J; Stamatakis K; Dotor J; Majano PL; Fresno M; Cabañas C; López-Cabrera M
    J Pathol; 2013 Dec; 231(4):517-31. PubMed ID: 24114721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of mesothelial genes in ovarian carcinoma cells is associated with an unfavorable clinical outcome and the promotion of cancer cell adhesion.
    Ojasalu K; Brehm C; Hartung K; Nischak M; Finkernagel F; Rexin P; Nist A; Pavlakis E; Stiewe T; Jansen JM; Wagner U; Gattenlöhner S; Bräuninger A; Müller-Brüsselbach S; Reinartz S; Müller R
    Mol Oncol; 2020 Sep; 14(9):2142-2162. PubMed ID: 32533757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway.
    Yasui H; Kajiyama H; Tamauchi S; Suzuki S; Peng Y; Yoshikawa N; Sugiyama M; Nakamura K; Kikkawa F
    Clin Exp Metastasis; 2020 Feb; 37(1):145-158. PubMed ID: 31541326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Host Wnt5a Potentiates Microenvironmental Regulation of Ovarian Cancer Metastasis.
    Asem M; Young AM; Oyama C; Claure De La Zerda A; Liu Y; Yang J; Hilliard TS; Johnson J; Harper EI; Guldner I; Zhang S; Page-Mayberry T; Kaliney WJ; Stack MS
    Cancer Res; 2020 Mar; 80(5):1156-1170. PubMed ID: 31932454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocyte growth factor secreted by ovarian cancer cells stimulates peritoneal implantation via the mesothelial-mesenchymal transition of the peritoneum.
    Nakamura M; Ono YJ; Kanemura M; Tanaka T; Hayashi M; Terai Y; Ohmichi M
    Gynecol Oncol; 2015 Nov; 139(2):345-54. PubMed ID: 26335595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro mesothelial clearance assay that models the early steps of ovarian cancer metastasis.
    Davidowitz RA; Iwanicki MP; Brugge JS
    J Vis Exp; 2012 Feb; (60):. PubMed ID: 22371143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miRNA-301b-3p accelerates migration and invasion of high-grade ovarian serous tumor via targeting CPEB3/EGFR axis.
    Liu F; Zhang G; Lv S; Wen X; Liu P
    J Cell Biochem; 2019 Aug; 120(8):12618-12627. PubMed ID: 30834603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Vivo and Ex Vivo Analysis of Omental Adhesion in Ovarian Cancer.
    Harper EI; Hilliard TS
    Methods Mol Biol; 2022; 2424():199-216. PubMed ID: 34918297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum.
    Kenny HA; Krausz T; Yamada SD; Lengyel E
    Int J Cancer; 2007 Oct; 121(7):1463-72. PubMed ID: 17546601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.